In addition, we found that AD-MSCs could effectively inhibit the proliferation and migration of microglia and reduce the secretion of inflammatory factors TNF-α and IL-6, reflecting the anti-inflammatory capacity of AD-MSCs, which is similar to those of previous studies [24, 25]. The gene discussed is IL6; the disease is Alzheimer disease.